MEDIFAST INC — Director's Dealing 2023

Sep 15, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2023-09-13

Reporting Person: MacKenzie Jonathan Barrett (VP, Finance & CAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-09-13	Common Stock	F	10	$81.08	Disposed	1486	Direct

Footnotes

F1: These shares were withheld to satisfy the tax withholding obligations upon vesting of an equity award.

F2: This equity award vested on September 13, 2023. The price used for withholding was the closing sales price of the vesting date.